First-day Versus Early Drain Removal Following PD: a Randomized Controlled Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorCasa di Cura Dott. Pederzoli

About this trial

Pancreatic surgery is a complex discipline with a high risk of post-operative morbidity such as pancreatic fistula (POPF) with variable impact on clinical outcome. Controversies on ID placement have emerged from both randomized and non-randomized clinical studies investigating its possible role in increasing POPF and postoperative morbidity. The optimal timing for drain removal after PD is still a subject of debate: most studies have shown that outcomes are best when ID are removed in postoperative day (POD) 3 when POPF is excluded.

AIM we aim to compare postoperative surgical outcomes after PD in patients with low/medium risk for POPF (ISGPS risk class A-B-C), who undergo POD1 drains removal versus POD3 removal.

Primary aim: 1) grade B/C POPF; 2) post-pancreatectomy hemorrhage (PPH). Secondary aims: occurrence of fluid collection, sepsis, SSI, need for reintervention, length of stay, CD\>3, 90 days mortality, re-admission.

Study Design:

This is a randomized, controlled, open-label study. All patients will be randomized on POD1, using computer-generated randomization codes.

Group A: Drain removal on POD 1 (in case of POD 1 DFA\< 300 U/L) Group B: Drain removal on POD 3 (in case of POD 1 DFA\< 300 U/L)

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients (age ≥ 18 or < 85 years) undergoing elective pancreaticoduodenectomy providing informed consent.

Intraoperative low to moderate risk for POPF (ISGPS class A-B-C)

POD 1 DFA < 300U/L

Disqualifiers

Age <18 or >85

Patients with high risk of developing pancreatic fistula (ISGPS class D)

Intraoperative positioning of external or internal pancreatic stent

POD 1 DFA ≥300

Trial design

Design model

Parallel

Treatments tested in this trial

  • 1st day removal of abdominal drain

    Behavioral

    once POPF is excluded in middle-low risk pancreatic resection, abdominal drains can be removed

Treatment groups

224 Participants
are divided into 2 treatment groups
Group A: Drain removal on POD 1Active comparator 1 intervention
Group B: Drain removal on POD 3Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

occurrence of one or more pancreas-specific complications

complications are defined according to ISGPS as:1) grade B/C POPF; 2) post-pancreatectomy hemorrhage (PPH).

Time frame
up to 90 days after surgery

Secondary outcomes

1

occurrence of general post operative complications

occurrence of fluid collection, sepsis, SSI, need for reintervention, length of stay, CD\>3, 90 days mortality, re-admission

Time frame
up to 90 days after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Casa di Cura Dott. Pederzoli

Lead sponsor

University of Padova

Collaborator